DANIPHARM A/S: Financial statements 2015
CVR: 12335040
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
DANIPHARM A/S (CVR 12335040) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 85,065,452 and a net result of DKK 11,265,725 compared with DKK 8,871,761 the year before. That is a decrease of 5.6% compared with the year before. The profit margin was 13.2%. Equity in the 2015 report amounted to DKK 26,515,586. The solvency ratio was 61.9%. The company had 23 employees in the financial year.
- Revenue
- DKK 85,065,452
- Gross Profit
- DKK 34,860,677
- Profit/Loss
- DKK 11,265,725
- Equity
- DKK 26,515,586
- Total Assets
- DKK 42,827,535
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 85.1 mio. | 34.9 mio. | 11.3 mio. | 26.5 mio. | 23 |
| 2014 | 90.1 mio. | 30.9 mio. | 8.9 mio. | 15.3 mio. | 23 |
| 2013 | 84.8 mio. | 21.9 mio. | 232 t. | 6.4 mio. | 21 |
Official annual report
How creditworthy is DANIPHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout DANIPHARM A/S
DANIPHARM A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1988. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Niels Ulrik Heine (chair), Helle Rørvig and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 37,586,751 and a net result of DKK 13,717,304 compared with DKK 5,113,647 the year before. Equity in the 2025 report amounted to DKK 60,280,949.